Experimental Drug T-DM1 Clinical Trials Encouraging Against Aggressive Breast Cancer
For Bridget Spence, graduation from college was a short-lived joy. Just one week after receiving her degree, a medical diagnosis sent her reeling.
"I was diagnosed with stage 4 breast cancer in 2005. Cancer was in my lymph nodes, liver and breast at the time of my diagnosis," she told ABC News.
She had HER2-positive breast cancer, a particularly aggressive form of the disease. For four years, her cancer progressed, and a combination of drugs kept it stable for a while.
But about a year ago, her cancer started growing again, and she wasn't sure what she would do. That's when her doctors told her about a trial of an experimental drug, called T-DM1, designed to target and attack cancer cells in HER2-positive breast cancer patients.
While other drugs couldn't shrink Spence's cancer, she said T-DM1 did, and kept it at bay for nine months.
CC:Read More From Source
Related ArticlesLeBron James issues call for justice after Heat's 27-game winning streak ends against Bulls
Mar 28, 2013, 2013 05:36:38 AM
The Germany coach defended the Bayern Munich shot-stopper after his 47th minute howler prevented his country from keeping a clean sheet against Kazakhstan
Mar 27, 2013, 2013 05:32:57 AM
The Three Lions captain was disappointed to surrender the advantage against Montenegro but is adamant that his side can reel their opponents in and qualify as winners
Mar 27, 2013, 2013 05:31:46 AM
The Bleus star was disappointed with his side's 1-0 World Cup qualifying loss against Spain at the Stade de France
Mar 27, 2013, 2013 05:30:20 AM
The Galatasaray midfielder is a major doubt for the Oranje's game against Romania on March 26, though the former Bayern Munich boss could at least be pleased with the 3-0 result
Mar 23, 2013, 2013 04:53:44 AM